Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VBI Vaccines Inc.    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo VBI Vaccines Inc.
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Number of employees : 125 people.
Sales per Businesses
2019
USD (in Million)%
Research & Development Service1.6975.9%
Vaccines0.53624.1%
Sales per Regions
20182019Delta
USD (in Million)%USD (in Million)%
China/Hong Kong2.6779.5%1.6473.6% -38.7%
Israel0.43513%0.45520.5% +4.6%
Europe0.2537.5%0.1315.9% -48.22%
Managers
NameAgeSinceTitle
Jeff Baxter572016President, Chief Executive Officer & Director
Steven H. Gillis, Dr.662016Chairman
Christopher McNulty422019CFO, Director & Head-Business Development
David Evander Anderson, Dr.492016Chief Scientific Officer
Francisco Diaz-Mitoma, Dr.642016Chief Medical Officer
Michel de Wilde, Dr.692016Independent Director
Blaine H. McKee, Dr.542019Independent Director
Joanne Cordeiro612019Independent Director
Damian Braga-2020Director
Nell Beattie312017Chief Business Officer
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 178,257,199 120,145,058 67.4% 0 0.0% 67.4%
Shareholders
NameEquities%
Perceptive Advisors LLC 45,951,556 25.8%
ARCH Venture Partners LLC 13,026,057 7.31%
OPKO Health, Inc. 6,678,751 3.75%
BlackRock Fund Advisors 4,136,066 2.32%
Pontifax Management Co. Ltd. 3,723,654 2.09%
The Vanguard Group, Inc. 2,694,084 1.51%
Geode Capital Management LLC 2,447,848 1.37%
SSgA Funds Management, Inc. 2,052,366 1.15%
683 Capital Management LLC 2,000,000 1.12%
Clarus Ventures LLC 1,866,495 1.05%
Company contact information
VBI Vaccines, Inc.
222 3rd Street
Suite 2241
Cambridge, MA 02142

Phone : +1.617.830.3031
Web : http://www.vbivaccines.com
Sector Biotechnology & Medical Research - NEC